- Home
- SRPT vs PRA Comparison
SRPT vs PRA Comparison
Compare SRPT & PRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SRPT | PRA |
|---|---|---|
| Founded | 1980 | 1976 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Property-Casualty Insurers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.5B | 1.2B |
| IPO Year | 2000 | 2000 |
Fundamental Metrics
Financial Performance| Metric | SRPT | PRA |
|---|---|---|
| Price | $21.78 | $24.71 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 28 | 2 |
| Target Price | ★ $25.40 | $25.00 |
| AVG Volume (30 Days) | ★ 3.2M | 632.7K |
| Earning Date | 05-05-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ 0.99 |
| Revenue | ★ $2,198,237,000.00 | $1,098,028,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $24.89 |
| Revenue Growth | ★ 15.58 | N/A |
| 52 Week Low | $10.42 | $22.72 |
| 52 Week High | $64.80 | $24.85 |
Technical Indicators
Market Signals| Indicator | SRPT | PRA |
|---|---|---|
| Relative Strength Index (RSI) | 61.69 | 57.92 |
| Support Level | $20.61 | $23.88 |
| Resistance Level | $23.01 | N/A |
| Average True Range (ATR) | 1.24 | 0.14 |
| MACD | 0.58 | 0.00 |
| Stochastic Oscillator | 71.50 | 66.28 |
Price Performance
Historical ComparisonAbout SRPT Sarepta Therapeutics Inc. (DE)
Sarepta Therapeutics Inc is a commercial-stage biopharmaceutical company focused on the discovery and development of RNA-targeted therapies, gene therapies, and other genetic medicines for rare diseases, particularly neuromuscular disorders. The company has developed approved treatments for Duchenne muscular dystrophy, including EXONDYS 51, VYONDYS 53, AMONDYS 45, and ELEVIDYS, and is advancing additional therapeutic candidates for neuromuscular and other rare diseases. The company operates in one segment: discovering, developing, manufacturing, and delivering therapies to patients with rare diseases.
About PRA ProAssurance Corporation
ProAssurance Corp is a holding company for property and casualty insurance companies. The company's wholly-owned insurance subsidiaries provide professional liability insurance for healthcare professionals and facilities, professional liability insurance for attorneys, and workers' compensation insurance. ProAssurance reports operating results in five segments: Specialty Property and Casualty, Workers' Compensation, Segregated Portfolio Cell Reinsurance, Lloyd's Syndicate, and Corporate. ProAssurance generates the vast majority of its revenue from its Specialty P&C activities, followed by Worker's Compensation.